期刊文献+

黄芪护心胶囊治疗慢性充血性心力衰竭的临床观察 被引量:5

Observation of Huangqihuxin capsule on the treatment of chronic congestive heart failure
下载PDF
导出
摘要 目的观察黄芪护心胶囊治疗慢性充血性心力衰竭(CHF)的临床疗效及安全性。方法96例CHF患者随机分为2组,对照组46例,予西医常规治疗;治疗组50例,在对照组基础上予黄芪护心胶囊,每次5粒,每日3次口服。2组均1个月为1个疗程,观察临床疗效及心功能指标变化。结果治疗组总有效率92.0%,对照组76.1%。2组比较差异有统计学意义(P<0.05);治疗组心功能参数心输出量(CO)、每搏输出量(SV)、射血分数(LVEF)及舒张晚期与舒张早期充盈速度比(A/E)等好转情况均明显优于对照组(P<0.05)。结论黄芪护心胶囊治疗CHF安全有效,值得临床推广。 Objective To observe chnical effect of Huangqihuxin capsule in treating chronic heart failure (CHF) and the improvement of life quality with CHF patients. Methods 96 patients with CHF were randomly divided into two groups. 46 patients in control group were treated by routine treatment of western medicine. 50 patients in treatment group were treated by combination of routine therapy and Huangqihuxin capsule, 5 pills, thrice a day. The course was 30 days in two groups. The changes of overall curative effect and heart function of CHF patients were observed. Results The total ef- fective rate was 92.0% in treatment group and 76.1% in control group. There was difference between two groups on total effective rate ( P 〈 0.05). The improvement of heart function including cardiac output (CO), stroke volume (SV), LVEF and ME ratio in treatment group were superior to those in the control group ( P 〈 0.05). Conclusion Huangqihuxin capsule was a safe and effective on the treatment of chronic heart failure.
出处 《河北中医》 2009年第4期500-501,共2页 Hebei Journal of Traditional Chinese Medicine
关键词 胶囊 心力衰竭 充血性 慢性病 中医药疗法 Huangqihuxin capsule Chronic congestive heart failure
  • 相关文献

参考文献3

二级参考文献48

  • 1王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:90
  • 2Goldstein S, Ali AS, Sabbah H, et al. Ventricular remodeling. Mechanism and prevention. Cardiol Clin, 1998,16(4):623-632.
  • 3Dzau VJ, Hirsch AT. Emerging role of tissue rennin-angiotensin systems in congestive heart failure. Eur Heart J, 1990,11 (Suppl B) :65-71.
  • 4Smits JF,van Krimpen C, Schoemaker RG, et al. Angiotensin Ⅱ receptor blockade after myocardial infarction in rats:effects on hemodynamics, myocardial DNA synthesis, and interstitial collagen content. J Cardiovasc Pharmacol, 1992,20(5) :772-778.
  • 5Taylor K, Patten RD, Smith JJ, et al. Divergent effects of angiotensin-converting enzyme inhibition and angiotensin Ⅱ receptor antagonism on myocardial cellular proliferation and collagen deposition after myocardial infarction in rats. J Cardiovasc pharmacol, 1998 ,31 (5) :654-660.
  • 6Jalowy A, Schulz R, Dorge H, et al. Infarct size reduction by ATI-receptor blockade through a signal cascade of AT2-receptor activation, bradykinin and prostaglandins in pigs. JAm Coil Cardiol, 1998 ,32(4): 1787-1796.
  • 7Goodfriend TL, Elliott ME, Catt KJ, et al. Angiotensin receptors and their antagonist. N Engl J Med, 1996,334(25),1649-1654.
  • 8Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol, 1997, 80(11A) : 15L-25L
  • 9Braunwald E,Bristow MR Congestive heart failure: fifty years of progress. Circulation, 2000, 102(20 Suppl 4) : Ⅳ14-23.
  • 10Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) : developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation, 2005, 112 (12) :e154-235.

共引文献3821

同被引文献43

引证文献5

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部